The protein YfbV is a membrane protein found in Escherichia coli. Research suggests it has roles in cell division and adherence . Furthermore, overexpression studies indicate that membrane proteins such as YfbV might not always fold correctly when targeted to E. coli membranes .
Escherichia coli ( E. coli) O9:H4 is a serotype of E. coli . Serotyping of E. coli O9 has identified nine different serotypes . E. coli O9:H4 can be a diarrheagenic E. coli .
YfbV was initially identified in a genome-wide screen for its ability to inhibit cell division, leading to the formation of filamentous cells when expressed at high levels in E. coli . It localizes to the cell division site and exhibits some specificity for glycan binding . YtfB, which shares homology with the virulence factor OapA in Haemophilus influenzae, binds with high affinity to N’acetylglucosamine and mannobiose glycans . Studies using the uropathogenic E. coli strain UTI89 have shown that the absence of ytfB reduces the bacteria's ability to adhere to kidney cells, but not bladder cells, suggesting a specific role in the early stages of ascending urinary tract infections .
Research has indicated that YtfB interacts with proteins involved in cellular function and with hypothetical fimbrial-like proteins YbgP, YbgD, and YgiL . Additionally, YfbV may interact with the cell division protein DamX .
KEGG: ecx:EcHS_A2444
For recombinant production of YfbV, E. coli-based expression systems remain the gold standard for prokaryotic membrane proteins. The BL21(DE3) strain combined with pET vector systems offers high yield potential. Consider these methodological approaches:
| Expression System | Advantages | Limitations | Recommended Tags |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, economical, rapid growth | Potential inclusion body formation | His6, MBP |
| C41/C43(DE3) | Optimized for membrane proteins | Lower yield than BL21 | His6, SUMO |
| Lemo21(DE3) | Tunable expression | Requires optimization | His6 |
| Cell-free systems | Avoids toxicity issues | Expensive, lower yield | His6, Strep-tag |
Expression should be optimized by testing various induction temperatures (16-37°C), IPTG concentrations (0.1-1.0 mM), and induction times (4-24 hours). For YfbV specifically, pilot experiments suggest that lower temperatures (16-20°C) with longer induction times may improve proper membrane integration .
Purified YfbV should be stored in a Tris-based buffer with 50% glycerol for stability. The manufacturer's recommendations indicate storage at -20°C for regular use, while extended storage should be at -20°C or -80°C to maintain protein integrity. Importantly, repeated freeze-thaw cycles significantly reduce activity and should be avoided; working aliquots can be maintained at 4°C for up to one week .
For research requiring extended protein stability, consider these evidence-based preservation strategies:
Add stabilizing agents such as glycerol (10-50%), sucrose (5-20%), or specific detergents
Maintain pH between 7.0-8.0 using Tris or phosphate buffers
Include reducing agents (1-5mM DTT or 1-2mM β-mercaptoethanol) if cysteine residues are present
For long-term storage, flash freeze small aliquots in liquid nitrogen before transferring to -80°C
Determining the membrane topology of YfbV requires a multi-method approach. Begin with computational predictions using tools like TMHMM, HMMTOP, and TopPred, which analyze the amino acid sequence for hydrophobic segments and following the positive-inside rule.
For experimental validation, consider these techniques:
Substituted cysteine accessibility method (SCAM): Introduce cysteine residues at various positions and test accessibility to membrane-impermeable sulfhydryl reagents
Protease protection assays: Treat membrane vesicles with proteases and analyze protected fragments
Fluorescence quenching: Attach fluorophores to specific residues and measure accessibility to quenchers
Epitope insertion and antibody binding: Insert epitope tags at various positions and test antibody accessibility in membrane-permeabilized versus intact cells
Each method has specific requirements:
| Method | Key Reagents | Controls Needed | Analysis Approach |
|---|---|---|---|
| SCAM | Maleimide reagents, cysteine-free base protein | Cysteine-less control, permeabilized samples | Mass spectrometry, fluorescence |
| Protease protection | Trypsin, chymotrypsin | Detergent-solubilized samples | Western blot, mass spectrometry |
| Fluorescence quenching | Fluorophores, collisional quenchers | Solubilized protein | Stern-Volmer plots |
| Epitope mapping | HA, FLAG, or c-Myc tags | Permeabilized controls | Immunofluorescence, flow cytometry |
To identify YfbV protein-protein interactions, employ a combination of in vitro and in vivo techniques:
Co-immunoprecipitation (Co-IP): Use anti-YfbV antibodies or antibodies against the recombinant tag to pull down protein complexes from cell lysates, followed by mass spectrometry
Bacterial two-hybrid system: Particularly useful for membrane proteins, testing potential interactions in a cellular context
Pull-down assays: Immobilize purified YfbV on resin via its tag and incubate with cell lysates
Crosslinking mass spectrometry: Use membrane-permeable crosslinkers like DSP or formaldehyde to capture transient interactions
Proximity labeling: Fuse YfbV to BioID or APEX2 to biotinylate proximal proteins
For each interaction identified, validation experiments should include:
Reciprocal pull-downs
Domain mapping to identify interaction regions
Competition assays with purified components
Functional assays to demonstrate biological relevance
YfbV's role in membrane dynamics can be investigated through various biophysical and imaging approaches:
Fluorescence recovery after photobleaching (FRAP): Fuse YfbV to GFP and measure lateral mobility within the membrane
Förster resonance energy transfer (FRET): Assess proximity relationships with other membrane components
Giant unilamellar vesicles (GUVs): Reconstitute YfbV in artificial membrane systems to study its effect on membrane curvature and domain formation
Cryo-electron microscopy: Visualize YfbV arrangements within the membrane at near-atomic resolution
Methodological workflow should include:
Construct fluorescent protein fusions ensuring proper membrane localization
Confirm fusion protein functionality through complementation assays
Employ super-resolution microscopy (STORM, PALM) to visualize nanoscale organization
Correlate localization patterns with specific membrane lipid compositions using lipid-binding probes
Membrane protein solubilization requires careful detergent selection. For YfbV, a systematic approach should test multiple detergent classes:
| Detergent Class | Examples | CMC Range | Recommended Starting Concentration |
|---|---|---|---|
| Mild non-ionic | DDM, LMNG | 0.01-0.2 mM | 1-2% for extraction, 2-3× CMC for purification |
| Zwitterionic | LDAO, FC-12 | 1-4 mM | 1-2% for extraction, 3-5× CMC for purification |
| Glycosides | OG, NG | 18-25 mM | 2% for extraction, 3-4× CMC for purification |
| Amphipols | A8-35, PMAL | N/A | 1:3 protein:amphipol ratio |
For purification, employ a multi-step approach:
Initial capture via affinity chromatography (IMAC for His-tagged constructs)
Size exclusion chromatography to remove aggregates and assess oligomeric state
Optional ion exchange step for removing contaminants
Quality control should include SDS-PAGE, Western blotting, and dynamic light scattering to assess purity, identity, and monodispersity respectively .
Since the specific function of YfbV is not fully characterized, a comprehensive functional assessment approach is recommended:
Lipid binding assays: Test binding to various lipids using liposome flotation or lipid overlay assays
Ion flux measurements: Reconstitute YfbV in liposomes loaded with fluorescent indicators to detect potential channel/transporter activity
Growth complementation: Construct deletion strains and test whether YfbV expression rescues phenotypes
Stress response analysis: Examine changes in expression under various stress conditions (pH, temperature, osmotic shock)
Each assay should include appropriate controls:
Negative controls: Empty vectors, inactive mutants
Positive controls: Well-characterized proteins with similar predicted functions
Specificity controls: Related proteins from the same family to determine functional uniqueness
Structure-function analysis requires systematic mutagenesis combined with functional readouts:
Alanine scanning: Replace conserved residues with alanine to identify functional hotspots
Domain swapping: Exchange domains with homologous proteins to map functional regions
Cysteine crosslinking: Introduce pairs of cysteines to constrain conformational dynamics
Truncation analysis: Create N- and C-terminal truncations to identify minimal functional units
Data analysis should correlate structural features with functional outcomes:
| Mutation Type | Design Strategy | Functional Assessment | Structural Interpretation |
|---|---|---|---|
| Conserved residues | Sequence alignment across homologs | Activity assays | Critical functional sites |
| Charged clusters | Focus on membrane-proximal regions | Localization, complex formation | Protein-protein interaction sites |
| Hydrophobic patches | Surface mapping | Membrane association | Lipid interaction surfaces |
| Glycine/proline | Target potential hinge regions | Conformational dynamics | Flexibility requirements |
The UPF0208 family remains largely uncharacterized, making comparative analysis particularly valuable. Perform sequence and structural comparisons across bacterial species to identify:
Conserved sequence motifs that may indicate functional domains
Evolutionary patterns suggesting co-evolution with interaction partners
Gene neighborhood analysis to identify potential functional associations
A methodological approach should include:
Multiple sequence alignment using MUSCLE or MAFFT
Phylogenetic tree construction using maximum likelihood methods
Conservation mapping onto predicted structural models
Comparative genomic analysis using tools like STRING database
To study YfbV expression and regulation, employ these approaches:
Promoter fusion assays: Fuse the yfbV promoter to reporter genes (GFP, lacZ) to monitor expression under different conditions
qRT-PCR: Quantify yfbV transcript levels in response to environmental stimuli
ChIP-seq: Identify transcription factors binding to the yfbV promoter region
RNA-seq: Compare transcriptomes between wild-type and yfbV deletion strains
For experimental design, consider:
Testing conditions relevant to E. coli physiology (nutrient limitation, pH changes, antibiotic stress)
Including appropriate time courses to capture dynamic regulation
Using multiple strains (laboratory, clinical isolates) to assess strain-specific regulation
Correlating expression with phenotypic assays to determine functional consequences
Based on its membrane localization and protein family, YfbV may play roles in:
Membrane integrity maintenance during environmental stress
Protein complex scaffolding at specific membrane regions
Small molecule transport or sensing
Cell division processes through localization at division sites
Experimental approaches to test these hypotheses:
Membrane integrity assays using fluorescent dyes in wild-type versus deletion strains
Lipidomic analysis to detect changes in membrane composition
Localization studies during cell cycle and under various stresses
Metabolomic analysis to identify potential transported substrates
For researchers interested in developing molecular tools to probe YfbV function:
Fragment-based screening: Test libraries of small molecules for binding to purified YfbV
In silico docking: Use homology models to identify potential binding pockets
Peptide-based inhibitors: Design peptides mimicking interaction interfaces
Genetic suppressor screening: Identify mutations that enhance or suppress yfbV deletion phenotypes
A systematic workflow should include:
Target validation through genetic and biochemical approaches
Primary screening assays with appropriate controls
Secondary assays to confirm specificity and mechanism
Structure-activity relationship studies for promising leads